Crescent Capital BDCCCAP
CCAP
About: Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
299% more call options, than puts
Call options by funds: $507K | Put options by funds: $127K
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
7% more funds holding
Funds holding: 82 [Q3] → 88 (+6) [Q4]
3% more capital invested
Capital invested by funds: $320M [Q3] → $332M (+$11.1M) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]
0.61% less ownership
Funds ownership: 47.15% [Q3] → 46.54% (-0.61%) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$16
4%
downside
Avg. target
$17.25
4%
upside
High target
$18.50
11%
upside
2 analyst ratings
1 positive
50%
1 neutral
50%
0 negative
0%
Wells Fargo Finian O'Shea 50% 1-year accuracy 30 / 60 met price target | 4%downside $16 | Equal-Weight Maintained | 28 Apr 2025 |
Keefe, Bruyette & Woods Ryan Lynch 33% 1-year accuracy 1 / 3 met price target | 11%upside $18.50 | Outperform Maintained | 8 Apr 2025 |
Financial journalist opinion
Based on 6 articles about CCAP published over the past 30 days
Negative
Zacks Investment Research
7 hours ago
Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Lag Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.63 per share a year ago.
Neutral
GlobeNewsWire
9 hours ago
Crescent Capital BDC, Inc. Reports First Quarter 2025 Earnings Results; Declares a Second Quarter Base Dividend of $0.42 Per Share
LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.45 per share and net income of $0.11 per share, for the quarter ended March 31, 2025. Net asset value (NAV) per share was $19.62 at March 31, 2025 compared to $19.98 as of December 31, 2024.
Neutral
Seeking Alpha
1 week ago
My Income Portfolio: In The Garden Of Eden
Total Return can be misleading if not supported by NAV growth, as it may include unsustainable distributions and Return of Capital. Behavioral finance shows markets are irrational, making it crucial to consider practical aspects beyond theoretical Total Return calculations. I believe that NAV performance can affect our discretion in the reinvestment choices for the distributions we receive from our savings much more than Total Return.
Neutral
Business Wire
1 week ago
Crescent Capital Group Appoints Jason Breaux as Head of Private Credit
LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP, a leading alternative credit investment firm, announced today the appointment of Jason Breaux as Head of Private Credit. In this role, Mr. Breaux will lead the firm's private credit business and will focus on platform-wide growth, expanding investment capabilities, and continuing to elevate the Crescent brand. Mr. Breaux will continue in his roles as Chief Executive Officer of Crescent Capital BDC, Inc. (NASDAQ: CCAP) and Chair of the Boa.
Neutral
GlobeNewsWire
3 weeks ago
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2025 Financial Results
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the first quarter ended March 31, 2025 on Wednesday, May 14, 2025 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, May 15, 2025 at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2025 financial results.
Positive
Seeking Alpha
3 weeks ago
I'm Buying 2 Income Machines With 5-12% Yields
Spring is an ideal time for income investors to revisit portfolios, focusing on quality stocks like Crescent Capital BDC and Federal Realty Trust. Crescent Capital BDC offers a 12.4% yield, strong dividend coverage, and a diversified, conservatively managed portfolio, trading at a 24% discount to NAV. Federal Realty Investment Trust has a 57-year dividend growth streak, high-quality retail assets, and a 4.8% yield, trading well below historical valuation norms.
Neutral
Seeking Alpha
1 month ago
Crescent Capital BDC: Solid Dividend Coverage Supports Return Potential
CCAP experienced a stock price drop of over 10% due to uncertainty about its income potential and value proposition. CCAP's portfolio is 90% first-lien debt, with 85% in non-cyclical industries, ensuring priority in capital collection and defensive positioning. Diversification is key: top 10 investments hold only 15% of the portfolio, with an average position of 0.5% and low non-accruals.
Positive
Seeking Alpha
1 month ago
Crescent Capital BDC: 11% Yield And 11% Discount Make It A Buy
Crescent Capital BDC, Inc. offers a 10.6% dividend yield and trades at an 11% discount to book value, making it a compelling income investment. CCAP's portfolio is conservatively managed with 90% senior secured loans and strong private equity sponsorship, with low non-accruals. Despite lower base rates, CCAP maintains solid returns, supported by a healthy balance sheet and stable NAV/share, with management expecting increased deal activity.
Neutral
Zacks Investment Research
1 month ago
Is the Options Market Predicting a Spike in Crescent Capital BDC (CCAP) Stock?
Investors need to pay close attention to Crescent Capital BDC (CCAP) stock based on the movements in the options market lately.
Positive
Seeking Alpha
2 months ago
Bargain Alert: I'm Buying These 7-11% Yields For Recurring Income
Market volatility underscores the need for income-producing assets; Crescent Capital BDC and Omega Healthcare Investors offer compelling value with strong fundamentals and attractive yields. Crescent Capital BDC carries a diversified portfolio, high-quality secured debt, robust liquidity, and an 11% dividend yield while trading at a 15% discount to NAV. Omega Healthcare Investors benefits from a stable triple-net lease model, improving operator fundamentals, and a 7.3% dividend yield, with potential for capital appreciation.
Charts implemented using Lightweight Charts™